Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation

Cancer Research

Volumn 63, Issue 4, 2003, Pages 756-759

  Satyamoorthy, Kapaettu ^a   Li, Gang ^a   Gerrero, Michelle R ^b   Brose, Marcia S ^b   Volpe, Patricia ^b   Weber, Barbara L ^b   Van Belle, Patricia ^c   Elder, David E ^c   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAS PROTEIN;

ARTICLE; AUTOCRINE EFFECT; BRAF GENE; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ENZYME ACTIVATION; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-8; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; TUMOR CELLS, CULTURED;

EID: 0037442752     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Meier, F., Satyamoorthy, K., Nesbit, M., Hsu, M. Y., Schittek, B., Garbe, C., and Herlyn, M. Molecular events in melanoma development and progression. Front. Biosci., 3: D1005-D1010, 1998.
2. Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J. L., Herlyn, D., Elder, D. E., Bondi, E., Guerry, D., Nowell, P., Clark, W. H., and et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res. 45: 5670-5676, 1985.
3. Halaban, R. Growth factors and melanomas. Semin. Oncol. 23: 673-681, 1996.
4. Lazar-Molnar, E., Hegyesi, H., Toth, S., and Falus, A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12: 547-554, 2000.
5. Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K., and Herlyn, M. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene, 20: 8125-8135, 2001.
6. Peyssonnaux, C., and Eychene, A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell., 93: 53-62, 2001.
7. Kolch, W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 Pt 2: 289-305, 2000.
8. Olson, M. F., and Marais, R. Ras protein signalling. Semin. Immunol., 12: 63-73, 2000.
9. Herlyn, M., and Satyamoorthy, K. Activated ras. Yet another player in melanoma? Am. J. Pathol., 149: 739-744, 1996.
10. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
11. Satyamoorthy, K., DeJesus, E., Linnenbach, A. J., Kraj, B., Kornreich, D. L., Rendle, S., Elder, D. E., and Herlyn, M. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res., 7(Suppl. 2): S35-S42, 1997.
12. Hsu, M-Y., Elder, D. E., and Herlyn, M. The Wistar (WM) melanoma cell lines. In: J. M. a. B. Palsson (ed.), Human Cell Culture, Vol. 3, pp. 259-274. London: Kluwer Acad., 1999.
13. Nesbit, M., Nesbit, H. K., Bennett, J., Andl, T., Hsu, M. Y., Dejesus, E., McBrian, M., Gupta, A. R., Eck, S. L., and Herlyn, M. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene, 18: 6469-6476, 1999.
14. Tada, M., Yokosuka, O., Omata, M., Ohto, M., and Isono, K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer (Phila.), 66: 930-935, 1990.
15. Rozycka, M., Collins, N., Stratton, M. R., and Wooster, R. Rapid detection of DNA sequence variants by conformation-sensitive capillary electrophoresis. Genomics, 70: 34-40, 2000.
16. Satyamoorthy, K., Li, G., Vaidya, B., Patel, D., and Herlyn, M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and β-catenin pathways. Cancer Res., 61: 7318-7324, 2001.
17. Davis, R. J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev., 42: 459-467, 1995.
18. Marais, R., Wynne, J., and Treisman, R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell, 73: 381-393, 1993.
19. Rodeck, U., Becker, D., and Herlyn, M. Basic fibroblast growth factor in human melanoma. Cancer Cells (Cold Spring Harbor), 3: 308-311, 1991.
20. Kinkl, N., Sahel, J., and Hicks, D. Alternate FGF2-ERK1/2 signaling pathways in retinal photoreceptor and glial cells in vitro. J. Biol. Chem., 276: 43871-43878, 2001.